OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Autoimmunity is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases	418
Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats	191
GILZ regulates type I interferon release and sequesters STAT1	158
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunity	152
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis	130
Advances in SLE classification criteria	130
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial	126
Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis	109
Editorial Board	105
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients	100
Immunological and fibrotic profiling in the NOD.c3c4 murine model of autoimmune cholangitis	96
Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: A comprehensive systematic analysis and modelling study	94
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis	94
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations	87
Ectopic CD4+ T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-γ induced microglia activation	77
Tfh cell-derived small extracellular vesicles exacerbate the severity of collagen-induced arthritis by enhancing B-cell responses	76
Autoimmune associated HLAs and T cell autoantigens exhibit common patterns across several autoimmune diseases	73
Lupus nephritis: new progress in diagnosis and treatment	72
Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia	55
Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation	53
Editorial Board	51
Editorial Board	51
Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus	50
Glycobiology of psoriasis: A review	49
Editorial Board	49

Sunscreen use associated with elevated prevalence of anti-nuclear antibodies in U.S. adults	46
Cellular communication network factor 3 contributes to the pathological process of rheumatoid arthritis through promoting cell senescence and osteoclastogenesis in the joint	45
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow	45
Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis	45
Antigenic mimicry – The key to autoimmunity in immune privileged organs	43
FAPI PET/CT for tracking disease trajectory in myositis-related interstitial lung disease	39
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies	39
Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes	38
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome	38
Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations	36
Mitochondrial dysfunction is a potential key mechanism for atherosclerosis predisposition in patients with systemic lupus erythematosus	35
Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus	35
Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis	33
Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice	33
LAT1 enables T cell activation under inflammatory conditions	33
Editorial Board	32
The complement system and human autoimmune diseases	32
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach	31
Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy	31
External and internal exposome as triggers of biological signalling in systemic sclerosis – A narrative synthesis	30
Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis	30
Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study	30
Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS proje	29
Familial patterns of alopecia areata: A systematic review and meta-analysis	29
Autoimmune markers and vascular immune deposits in Finkelstein-Seidlmayer vasculitis: Systematic literature review	29
Clinical utility of measuring CD4+ T follicular cells in patients with immune dysregulation	27
The role of gut flora-driven Th cell responses in preclinical rheumatoid arthritis	27
Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis	27
Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus	27
Antigen-specific immune reactions by expanded CD8+ T cell clones from HLA-B*27-positive patients with spondyloarthritis	26
Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study	26
Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice	26
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target	26
The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis	26
Pregnancy-related complications in systemic lupus erythematosus	26
Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis	25
Functional metagenomic analysis reveals potential inflammatory triggers associated with genetic risk for autoimmune disease	25
Differential changes in the gut microbiota between extrinsic and intrinsic atopic dermatitis	25
Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity	25
Coronavirus disease 2019, vaccination against coronavirus and immunoglobulin A-mediated diseases: systematic literature review	24
Alternate splicing converts human CD137 from costimulatory to immunosuppressive function	23
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study	23
LAMP3-mediated epithelial-mesenchymal transition promotes the invasion and excessive proliferation of fibroblast-like synoviocytes in rheumatoid arthritis	23
Temporal trajectories and DMARD therapy retention of rheumatoid arthritis patients with different autoimmune and inflammatory comorbidity profiles: a retrospective analysis	23
Environmental exposures as risk factors for idiopathic inflammatory myopathies	23
Evaluation of the mycophenolate mofetil–rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)	22
Interferon signature in giant cell arteritis aortitis	22
Recent advances in cutaneous lupus	22
Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis	22
T cell aging as a risk factor for autoimmunity	22

Pro-fibrotic effect of the susceptible gene PCSK5 in vascular fibrosis of Takayasu arteritis via TGF-β and SMAD3 signaling pathway activation	21
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients	21
Editorial Board	21
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome	20
Interleukin 17-producing C-C motif chemokine receptor 6 + conventional CD4+ T cells are arthritogenic in an animal model of spondyloarthritis	20
Acquired susceptibility to autoimmune diseases in pediatric patients with Escherichia coli infection: A population-matched retrospective cohort study	20
Extracellular vesicle autoantibodies	20
Gut microbiota in systemic lupus erythematosus: A fuse and a solution	20
Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases	19
JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study	19
Significance of anti-transcobalamin receptor antibodies in cutaneous arteritis revealed by proteome-wide autoantibody screening	19
Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice	19
Preliminary safety and efficacy of relmacabtagene autoleucel (relma-cel) in adults with moderately to severely active systemic lupus erythematosus: a phase I dose-escalation study	19
Methotrexate and low-dose prednisone in idiopathic retroperitoneal fibrosis: a randomised clinical trial	19
RNA-binding protein hnRNP UL1 binds κB sites to attenuate NF-κB-mediated inflammation	19
Interleukin-15 is a hair follicle immune privilege guardian	19
A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile	18
Pin1 maintains the effector program of pathogenic Th17 cells in autoimmune neuroinflammation	18
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitis	18
Natural IgG protects against early dissemination of vesicular stomatitis virus	18
2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis	18
CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus	18
Autoimmune diseases and the risk of bladder cancer: A Mendelian randomization analysis	18
T follicular helper cells in autoimmune diseases	18
Application of laboratory models for sarcoidosis research	18
Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: What we learnt from the explorative clinical trial	17
VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder – A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape	17
Acute-type acquired hemophilia A after COVID-19 mRNA vaccine administration: A new disease entity?	17
Association between age groups and relapse of type 1 autoimmune pancreatitis: a large-scale retrospective cohort study	17
Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis	17
Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells	17
Comprehensive description of adult-onset Still's disease after COVID-19 vaccination	17
Genetic and pharmacological targeting of GSDMD ameliorates systemic inflammation in macrophage activation syndrome	17
Altered glucose metabolism in B cells: Implications for the pathogenesis and treatment of autoimmune diseases	17
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases	17
Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients	17
Treatment of mixed connective tissue disease: A multicenter retrospective study	16
PD1+ innate lymphoid cells 3 predict JAK-dependent inflammation in rheumatoid arthritis	16
Corrigendum to “Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies” [J. Autoimmun. 126 (2022) 102774]	16
Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease	16
Amelioration of immunoglobulin A vasculitis by suppression of the pathological expansion of T follicular helper 17 cells	16
Cognitive dysfunction in SLE: An understudied clinical manifestation	16
PD-1 antibody interactions with Fc gamma receptors enable PD-1 agonism to inhibit T cell activation – therapeutic implications for autoimmunity	16
Chimeric antigen receptor T cell therapy: a new frontier therapeutic landscape in autoimmune diseases	16
Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma	16
Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination	16
A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus	15
Pathogenicity of functionally activated PD-1+CD8+ cells and counterattacks by muscular PD-L1 through IFNγ in myositis	15
Developmental drugs for sarcoidosis	15
Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis	15
Repeated immunization with ATRA-containing liposomal adjuvant transdifferentiates Th17 cells to a Tr1-like phenotype	15
Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets	15
Regulatory T cells effectively downregulate the autoimmune anti-MPO response and ameliorate anti-MPO induced glomerulonephritis in mice	15
Sonic hedgehog promotes synovial inflammation and articular damage through p38 mitogen-activated protein kinase signaling in experimental arthritis	15
Autoimmune hepatitis following COVID-19 vaccination	15
Outcome and prognosis of isolated carotid vasculitis	15